Literature DB >> 29785003

Publisher Correction: The gut-liver axis and the intersection with the microbiome.

Anupriya Tripathi1,2,3, Justine Debelius2, David A Brenner4, Michael Karin2,5, Rohit Loomba4,6, Bernd Schnabl7,8,6, Rob Knight9,10,11.   

Abstract

In the original version of Table 1 published online, upward arrows to indicate increased translocation of PAMPs were missing from the row entitled 'Translocation' for both the column on alcoholic liver disease and nonalcoholic fatty liver disease. This error has now been updated in the PDF and HTML version of the article.

Entities:  

Year:  2018        PMID： 29785003      PMCID： PMC7133393          DOI： 10.1038/s41575-018-0031-8

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  255 in total

1.  Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease.

Authors:  Anna Janina Engstler; Tobias Aumiller; Christian Degen; Marion Dürr; Eva Weiss; Ina Barbara Maier; Jörn Markus Schattenberg; Cheng Jun Jin; Cathrin Sellmann; Ina Bergheim
Journal:  Gut       Date:  2015-05-25       Impact factor: 23.059

2.  Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.

Authors:  R Olsson; E Björnsson; L Bäckman; S Friman; K Höckerstedt; B Kaijser; M Olausson
Journal:  J Hepatol       Date:  1998-03       Impact factor: 25.083

Review 3.  The continuing value of twin studies in the omics era.

Authors:  Jenny van Dongen; P Eline Slagboom; Harmen H M Draisma; Nicholas G Martin; Dorret I Boomsma
Journal:  Nat Rev Genet       Date:  2012-07-31       Impact factor: 53.242

4.  Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances Treg and TH17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding.

Authors:  Rui-Cong Chen; Lan-Man Xu; Shan-Jie Du; Si-Si Huang; He Wu; Jia-Jia Dong; Jian-Rong Huang; Xiao-Dong Wang; Wen-Ke Feng; Yong-Ping Chen
Journal:  Toxicol Lett       Date:  2015-11-23       Impact factor: 4.372

5.  Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis.

Authors:  Jiannis Vlachogiannakos; Nikos Viazis; Panagiota Vasianopoulou; Irene Vafiadis; Dimitrios G Karamanolis; Spiros D Ladas
Journal:  J Gastroenterol Hepatol       Date:  2013-03       Impact factor: 4.029

Review 6.  Bile acid metabolism and signaling.

Authors:  John Y L Chiang
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

7.  Tributyrin supplementation protects mice from acute ethanol-induced gut injury.

Authors:  Gail A Cresci; Katelyn Bush; Laura E Nagy
Journal:  Alcohol Clin Exp Res       Date:  2014-05-30       Impact factor: 3.455

8.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

9.  Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection.

Authors:  Alexa Weingarden; Antonio González; Yoshiki Vázquez-Baeza; Sophie Weiss; Gregory Humphry; Donna Berg-Lyons; Dan Knights; Tatsuya Unno; Aleh Bobr; Johnthomas Kang; Alexander Khoruts; Rob Knight; Michael J Sadowsky
Journal:  Microbiome       Date:  2015-03-30       Impact factor: 14.650

10.  Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet-Induced Liver Disease.

Authors:  Lucie Etienne-Mesmin; Matam Vijay-Kumar; Andrew T Gewirtz; Benoit Chassaing
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-05-05
View more
  7 in total

Review 1.  Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes.

Authors:  Michael Kriss; Elizabeth C Verna; Hugo R Rosen; Catherine A Lozupone
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

Review 2.  Microbiome diurnal rhythmicity and its impact on host physiology and disease risk.

Authors:  Samuel Philip Nobs; Timur Tuganbaev; Eran Elinav
Journal:  EMBO Rep       Date:  2019-03-15       Impact factor: 8.807

3.  Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.

Authors:  Gai Gao; Zhishen Xie; Er-Wen Li; Yong Yuan; Yu Fu; Pan Wang; Xiaowei Zhang; Yonghui Qiao; Jiangyan Xu; Christian Hölscher; Hui Wang; Zhenqiang Zhang
Journal:  J Nat Med       Date:  2021-02-15       Impact factor: 2.343

4.  Gut Microbiome Contributes to Liver Fibrosis Impact on T Cell Receptor Immune Repertoire.

Authors:  Qing Liang; Meina Zhang; Yudi Hu; Wei Zhang; Ping Zhu; Yujie Chen; Pengxin Xue; Qiyuan Li; Kejia Wang
Journal:  Front Microbiol       Date:  2020-11-27       Impact factor: 5.640

5.  The Protective Effects of Ganoderic Acids from Ganoderma lucidum Fruiting Body on Alcoholic Liver Injury and Intestinal Microflora Disturbance in Mice with Excessive Alcohol Intake.

Authors:  Ying-Jia Cao; Zi-Rui Huang; Shi-Ze You; Wei-Ling Guo; Fang Zhang; Bin Liu; Xu-Cong Lv; Zhan-Xi Lin; Peng-Hu Liu
Journal:  Foods       Date:  2022-03-25

Review 6.  The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome.

Authors:  Stephen Malnick; Yaakov Maor
Journal:  Visc Med       Date:  2020-04-23

Review 7.  Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer.

Authors:  Chenchen Bi; Geqiong Xiao; Chunyan Liu; Junwei Yan; Jiaqi Chen; Wenzhang Si; Jian Zhang; Zheng Liu
Journal:  Front Cell Dev Biol       Date:  2021-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.